<html>
<head>PUBMED IDs for CDH22</head>
<body bgcolor='#C5F0F2'><h1>CDH22</h1><a href='https://pubmed.ncbi.nlm.nih.gov/18495598/'>[Construction of a lentiviral vector for RNA interference of human CDH22 gene and its gene silencing effect in SW480 cells].</a> May 23  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18602983/'>Heterogeneity in gene loci associated with type 2 diabetes on human chromosome 20q13.1.</a> July 8  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19403372/'>[Establishment of a colorectal cancer cell line with PRL-3 and CDH22 gene knock-down by lentivirus-mediated RNA interference].</a> January 12  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19440036/'>PRL-3 promotes epithelial mesenchymal transition by regulating cadherin directly.</a> February 13  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19440017/'>A lower risk of dying from urological cancer in Down syndrome: clue for cancer protecting genes on chromosome 21.</a> July 18  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19440016/'>Significance of serum calcitonin gene-related peptide levels in prostate cancer patients receiving hormonal therapy.</a> July 18  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/25101798/'>High-density genotyping of immune loci in Kawasaki disease and IVIG treatment response in European-American case-parent trio study.</a>  2014   C14orf19 (1.4 × 10(-4)) and rs4889606 in the intron of the STX1B gene (6.95 × 10(-5)) in additive and dominant models, respectively. Our study suggests that genes and biological pathways involved in autoimmune diseases have an important role in the pathogenesis of KD and IVIG response mechanism.<br></body></html>
